Brief: Basilea Pharmaceutica Gets USD 2.5 Mln Milestone Payment For Cresemba Sales In Asia Pacific And China

Basilea Pharmaceutica AG, Allschwil

14/03/2025 06:18

March 14 (Reuters) - Basilea Pharmaceutica AG Allschwil BSLN.S:

STRONG CRESEMBA® (ISAVUCONAZOLE) SALES PERFORMANCE IN ASIA PACIFIC AND CHINA TRIGGERS MILESTONE PAYMENT TO BASILEA

BASILEA PHARMACEUTICA - LICENSE AGREEMENT BETWEEN BASILEA AND PFIZER FOR CRESEMBA COVERS EUROPE (EXCLUDING NORDIC COUNTRIES), CHINA AND 16 COUNTRIES IN ASIA PACIFIC

BASILEA PHARMACEUTICA - USD 2.5 MILLION MILESTONE PAYMENT TRIGGERED

Source text: ID:nGNEcg2gcv

Further company coverage: BSLN.S

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))